Elevated expression of CCND1 has also been hypothesized by Hoogstraat and colleagues to induce therapy resistance based on the findings of an investigation in which breast tumor samples were characterized before and after treatment to investigate the potential underlying mechanisms of chemotherapy resistance (Hoogstraat et al. 2022). The gene discussed is CCND1; the disease is breast neoplasm.